Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
| Conditions: | Carcinoma, Non-Small-Cell Lung|Carcinoma, Small Cell Lung|Mesothelioma |
| Start Date: | March 1, 2008 |
| Phase: | |
| Status: | Recruiting |
| NCT ID: | NCT00637624 |
| Study Type: | Interventional |
| Intervention: | Drug: N-Acetylcysteine|Drug: Placebo |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)|Primary Purpose: Prevention |
| Results: | No Results Available |
| Sponsors: | Rijnstate Hospital |
| Ages: | Adult|Senior |
| Enrollment: | 50 |
| Funded By: | Other |
| First Received: | March 11, 2008 |
| End Date: | July 1, 2010 |
| Last Updated: | October 20, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
